PL391035A1 - Markery chorób - Google Patents

Markery chorób

Info

Publication number
PL391035A1
PL391035A1 PL391035A PL39103508A PL391035A1 PL 391035 A1 PL391035 A1 PL 391035A1 PL 391035 A PL391035 A PL 391035A PL 39103508 A PL39103508 A PL 39103508A PL 391035 A1 PL391035 A1 PL 391035A1
Authority
PL
Poland
Prior art keywords
illness
markers
illness markers
Prior art date
Application number
PL391035A
Other languages
English (en)
Inventor
David Wraith
Heather Streeter
Original Assignee
Apitope Technology Bristol Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apitope Technology Bristol Limited filed Critical Apitope Technology Bristol Limited
Publication of PL391035A1 publication Critical patent/PL391035A1/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL391035A 2007-04-24 2008-04-23 Markery chorób PL391035A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0707933.8A GB0707933D0 (en) 2007-04-24 2007-04-24 Disease markers

Publications (1)

Publication Number Publication Date
PL391035A1 true PL391035A1 (pl) 2010-10-25

Family

ID=38135366

Family Applications (1)

Application Number Title Priority Date Filing Date
PL391035A PL391035A1 (pl) 2007-04-24 2008-04-23 Markery chorób

Country Status (13)

Country Link
US (1) US20100129853A1 (pl)
EP (1) EP2156190A2 (pl)
JP (1) JP2010525355A (pl)
CN (1) CN102317787A (pl)
AU (1) AU2008240367A1 (pl)
BR (1) BRPI0810559A2 (pl)
CA (1) CA2685113A1 (pl)
GB (1) GB0707933D0 (pl)
MX (1) MX2009011494A (pl)
NO (1) NO20093384L (pl)
PL (1) PL391035A1 (pl)
RU (1) RU2009142935A (pl)
WO (1) WO2008129296A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381535B2 (en) 2002-07-10 2008-06-03 The Board Of Trustees Of The Leland Stanford Junior Methods and compositions for detecting receptor-ligand interactions in single cells
ES2809171T3 (es) 2008-01-18 2021-03-03 Harvard College Métodos para detectar distintivos de enfermedades o afecciones en fluidos corporales
GB0903391D0 (en) * 2009-02-27 2009-04-08 Cambridge Entpr Biomarkers
EP2539470B1 (en) * 2010-02-24 2017-02-22 The Board of Trustees of The Leland Stanford Junior University Methods for autoimmune disease diagnosis, prognosis, and treatment
CN103124795A (zh) 2010-07-23 2013-05-29 哈佛大学校长及研究员协会 利用吞噬细胞检测疾病或病症的方法
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
SG10201505723UA (en) 2010-07-23 2015-09-29 Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
EP2965086A4 (en) 2013-03-09 2017-02-08 Harry Stylli Methods of detecting prostate cancer
WO2014164366A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting cancer
GB201400562D0 (en) 2014-01-14 2014-03-05 Orla Protein Technologies Ltd Protein coated polymeric substrate
EP3693742B1 (en) 2014-09-11 2022-04-06 Harry Stylli Methods of detecting prostate cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100795840B1 (ko) * 2002-08-08 2008-01-17 베일러 칼리지 오브 메디신 Ｔ세포의 분리 및 식별
EP2280285A1 (en) * 2003-09-15 2011-02-02 Oklahoma Medical Research Foundation Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases

Also Published As

Publication number Publication date
JP2010525355A (ja) 2010-07-22
BRPI0810559A2 (pt) 2015-02-10
US20100129853A1 (en) 2010-05-27
WO2008129296A3 (en) 2008-12-11
GB0707933D0 (en) 2007-05-30
AU2008240367A1 (en) 2008-10-30
WO2008129296A2 (en) 2008-10-30
EP2156190A2 (en) 2010-02-24
RU2009142935A (ru) 2011-05-27
CN102317787A (zh) 2012-01-11
CA2685113A1 (en) 2008-10-30
MX2009011494A (es) 2009-11-09
NO20093384L (no) 2010-01-18

Similar Documents

Publication Publication Date Title
IL202616A0 (en) Substituted imidazoheterocycles
ZA201001683B (en) Substituted piperidino-dihydrothienopyrimidines
PL391035A1 (pl) Markery chorób
EP2150906A4 (en) OBJECTS ASSOCIATED WITH A ZONE
EP2145244A4 (en) MOUSE
AP2010005314A0 (en) Nanodispersian
GB0804723D0 (en) Inedtification mark
GB0724412D0 (en) Marker
AU320442S (en) Marker
IL200965A0 (en) Substituted tetrahydropyrroloquinolines
GB0718496D0 (en) Markers
GB0616108D0 (en) Markers
GB0614801D0 (en) Markers
GB2444433B (en) Marker
GB2436401B (en) Marker
GB0701817D0 (en) Marker
GB0804417D0 (en) Markers
AU3595P (en) Goldust Strobilanthes anisophyllus
AU3606P (en) Jaywick xTriticosecale
GB0611651D0 (en) Marker
GB0710288D0 (en) Marker devices
GB0717492D0 (en) Turn case
GB0707258D0 (en) Marking
GB0705748D0 (en) Finally finally
ZA201000435B (en) Substituted imidazoheterocycles

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)